Ocuphire Pharma, Inc. (OCUP)
USD 1.17
(-12.03%)
USD 1.17
(-12.03%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 19.04 Million | 39.85 Million | 589 Thousand | - | - | - |
| Cost of Revenue | 6000.00 | 4000.00 | 4000.00 | 8000.00 | 3000.00 | 48.21 Thousand |
| Gross Profit | 19.04 Million | 39.84 Million | 585 Thousand | -8000.00 | -3000.00 | -48.21 Thousand |
| Operating Expenses | 29.6 Million | 21.62 Million | 23.29 Million | 9.46 Million | 4.19 Million | 20.48 Million |
| Selling, General and Administrative Expenses | 11.95 Million | 7.26 Million | 8.12 Million | 2.81 Million | 1.82 Million | 7.38 Million |
| Research and Development Expenses | 17.65 Million | 14.35 Million | 15.17 Million | 6.64 Million | 2.37 Million | 13.1 Million |
| Other Expenses | 1.83 Million | -14 Thousand | -157 Thousand | 9000.00 | -68 Thousand | - |
| Cost and Expenses | 29.61 Million | 21.62 Million | 23.29 Million | 9.46 Million | 4.19 Million | 20.53 Million |
| Operating Income | -10.56 Million | 18.22 Million | -22.7 Million | -19.96 Million | -4.19 Million | -20.53 Million |
| Interest Expense | - | 9000.00 | 2000.00 | 6.84 Million | 1.4 Million | - |
| Income Tax Expense | 12 Thousand | 315 Thousand | -159 Thousand | 6.85 Million | 1.34 Million | -161.14 Thousand |
| Earnings before Tax | -9.97 Million | 18.2 Million | -56.69 Million | -24.62 Million | -6.16 Million | -14.36 Million |
| Net Income | -9.98 Million | 17.88 Million | -56.53 Million | -31.47 Million | -7.51 Million | -14.36 Million |
| Earnings Per Share Basic | -0.46 | 0.90 | -3.81 | -6.75 | -10.56 | -20.95 |
| Earnings Per Share Diluted | -0.46 | 0.87 | -3.81 | -6.75 | -10.56 | -20.95 |
| Weighted Average Shares Outstanding | 21.58 Million | 19.93 Million | 14.85 Million | 4.66 Million | 711.2 Thousand | 685.73 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 21.58 Million | 20.59 Million | 14.85 Million | 4.66 Million | 711.2 Thousand | 685.73 Thousand |
| Gross Margin | 1.00 | 1.00 | 0.99 | - | - | - |
| EBIT Margin | -0.55 | 0.46 | -38.81 | - | - | - |
| Profit Margin | -0.52 | 0.45 | -95.98 | - | - | - |
| EBITDA | -9.96 Million | 18.23 Million | -56.68 Million | -19.96 Million | -4.19 Million | -14.32 Million |
| Earnings Before Tax Margin | -0.55 | 0.46 | -38.55 | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 1.11 Million | 1.71 Million | 1.69 Million | 19.04 Million | 11.93 Million | 3.67 Million |
| Cost of Revenue | 280 Thousand | 4.74 Million | 3000.00 | 6000.00 | 1000.00 | 1000.00 |
| Gross Profit | 832 Thousand | -3.03 Million | 1.68 Million | 19.04 Million | 11.93 Million | 3.67 Million |
| Operating Expenses | 9.44 Million | 9.41 Million | 7.11 Million | 29.6 Million | 5.54 Million | 9.06 Million |
| Selling, General and Administrative Expenses | 3.35 Million | 4.67 Million | 3.27 Million | - | 2.05 Million | 4.34 Million |
| Research and Development Expenses | 6.08 Million | 4.74 Million | 3.84 Million | - | 3.49 Million | 4.72 Million |
| Other Expenses | 563 Thousand | 2000.00 | 613 Thousand | 1.83 Million | 456 Thousand | 428 Thousand |
| Cost and Expenses | 9.44 Million | 9.41 Million | 7.12 Million | 29.61 Million | 5.54 Million | 9.06 Million |
| Operating Income | -8.32 Million | -7.7 Million | -5.42 Million | -10.56 Million | 6.38 Million | -5.38 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -1500.00 | -1500.00 | -2000.00 | 12 Thousand | -14 Thousand | 428 Thousand |
| Earnings before Tax | -7.76 Million | -7.1 Million | -4.79 Million | -9.97 Million | 5.57 Million | -4.96 Million |
| Net Income | -7.76 Million | -7.1 Million | -4.79 Million | -9.98 Million | 5.56 Million | -4.96 Million |
| Earnings Per Share Basic | -0.30 | -0.29 | -0.21 | - | 0.26 | -0.24 |
| Earnings Per Share Diluted | -0.30 | -0.29 | -0.21 | - | 0.25 | -0.24 |
| Weighted Average Shares Outstanding | 25.82 Million | 24.52 Million | 22.99 Million | 21.58 Million | 21.44 Million | 20.95 Million |
| Weighted Average Shares Outstanding (Diluted) | 25.82 Million | 24.52 Million | 22.99 Million | 21.58 Million | 22.4 Million | 20.95 Million |
| Gross Margin | 0.75 | -1.78 | 1.00 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | -7.49 | -4.50 | -3.21 | - | 0.54 | -1.35 |
| Profit Margin | -6.98 | -4.15 | -2.84 | -0.52 | 0.47 | -1.35 |
| EBITDA | -8.32 Million | -7.7 Million | -5.42 Million | - | 6.38 Million | -4.96 Million |
| Earnings Before Tax Margin | -7.49 | -4.50 | -3.21 | -0.55 | 0.54 | -1.47 |
PRME
1530
DNR
603809
TIL
SIHBY